2nd Quarter - Report

BOSTON SCIENTIFIC CORPORATION for BOSTON SCIENTIFIC CORPORATION

Firm
Client
Income
—
Expenses
$350,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

S. 232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax medical devicesH.R. 905 - Research and Development Tax Credit Extension Act of 2013-Amends the Internal Revenue Code to: (1) make permanent the tax credit for increasing research activities, (2) increase the rate of the alternative simplified research tax credit. H.R. 1295 - Medical Device Tax Elimination Act - Extends and enhances R&P tax credit H.R. 905 - Research and Development Tax Credit Extension Act of 2013 Comprehensive/Corporate tax reform Chairman's W&M Discussion Draft - Including lower corporate tax rate, research credit, transition and base erosion

LobbyistCovered position, as disclosed
BRENDA BECKER —
KRISTEN HEDSTROM —
STEVEN NEIL LAPIERRE —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 905 (113th), S. 232 (113th), H.R. 523 (113th), H.R. 1295 (113th)

Copyright/Patent/Trademark CPT

H.R. 2024 - End Anonymous Patents Act - - A bill to end frivolous Patent lawsuits H.R. 845 - Saving High-Tech Innovations from Egregious Legal Disputes Act of 2013 - A bill to end frivolous Patent lawsuits S. 1013 - Patent Abuse Reduction Act of 2013 - A bill to end frivolous Patent lawsuits S. 866 - Patent Quality Improvement Act of 2013 - A bill to end frivolous Patent lawsuitsYet to be introduced - Chairman Goodlatte discussion draft - To end frivolous Patent lawsuits

LobbyistCovered position, as disclosed
KRISTEN HEDSTROM —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 845 (113th), S. 866 (113th), H.R. 2024 (113th), S. 1013 (113th)

Budget/Appropriations BUD

H.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 -- Specifically provisions providing appropriations for the FDA's Center for Device and Radiological Health (CDRH) evaulation of medical technology -- In particular have been working on relief of 5% sequestration of user fees

LobbyistCovered position, as disclosed
KRISTEN HEDSTROM —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 933 (113th)

Computer Industry CPI

H.R. 624 - CyberIntelligence Sharing & Protection Act (CISPA) of 2013 - A bill to promote Industry and Government sharing of cyber intelligence

LobbyistCovered position, as disclosed
BRENDA BECKER —
KRISTEN HEDSTROM —
STEVEN NEIL LAPIERRE —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 624 (113th)

Health Issues HCR

Implementation Food and Drug Administration Safety and Innovation Act FDASIA - Public Law 112-144 H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 - Track and Trace Pedigree Program S. 957 - Drug Supply Chain Security Act - Track and Trace Pedigree Program

LobbyistCovered position, as disclosed
BRENDA BECKER —
KRISTEN HEDSTROM —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: S. 957 (113th), H.R. 1919 (113th)

Education EDU

S. 358 - STEM Master Teacher Corps Act of 2013 H.R. 1243 - Innovation Inspiration School Grant Program Act - to promote STEM education H.R. 1089 - Stepping up to STEM Act of 2013 - to promote STEM education

LobbyistCovered position, as disclosed
KRISTEN HEDSTROM —
STEVEN NEIL LAPIERRE —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1089 (113th), S. 358 (113th), H.R. 1243 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.